Drug delivery as a sustainable avenue to future therapies

被引:5
|
作者
Fuhrmann, Gregor [1 ]
机构
[1] Friedrich Alexander Univ Erlangen Nurnberg, Dept Biol, Pharmaceut Biol, Staudtstr 5, D-91058 Erlangen, Germany
关键词
Sustainable pharmacy; Infection research; Extracellular vesicles; Natural products; Education for sustainable development; Sustainable development goals; Academic publishing; FETAL BOVINE SERUM; EXTRACELLULAR VESICLES; MEMBRANE-VESICLES; EXOSOMES; SYSTEMS; NANOPARTICLES; DISCOVERY; BACTERIA;
D O I
10.1016/j.jconrel.2023.01.045
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Climate change and the need for sustainable, technological developments are the greatest challenges facing humanity in the coming decades. To address these issues, in 2015 the United Nations have established 17 Sustainable Development Goals. Anthropogenic climate change will not only affect everyone personally in the coming years, it will also reinforce the need to become more sustainable within drug delivery research. In 2021, I was appointed professor for pharmaceutical biology at the Friedrich-Alexander-University Erlangen-Nurnberg. Our research is at the interface between developing biogenic therapies and understanding of bacterial infections. In this contribution to the Orations - New Horizons of the Journal of Controlled Release, I would like to underline the need for future sustainable approaches in our research area, by highlighting selected examples from the fields of infection research, natural product characterisation and extracellular vesicles. My aim is to put into perspective current issues for these research topics, but also encourage our current student-training framework to contribute to education for sustainable development. This contribution is a personal statement to increase the overall awareness for sustainability challenges in drug delivery and beyond.
引用
下载
收藏
页码:746 / 754
页数:9
相关论文
共 50 条
  • [21] Future challenges for drug delivery
    Breimer, DD
    JOURNAL OF CONTROLLED RELEASE, 1999, 62 (1-2) : 3 - 6
  • [22] Drug delivery techniques of the future
    Stanley, T. H.
    SOUTHERN AFRICAN JOURNAL OF ANAESTHESIA AND ANALGESIA, 2008, 14 (01) : 46 - 50
  • [23] THE FUTURE OF LIPOSOMAL DRUG DELIVERY
    SZOKA, FC
    BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 1990, 12 (05) : 496 - 500
  • [24] Drug Nanocrystals: A Delivery Channel for Antiviral Therapies
    Chaturvedi, Akanksha
    Sharma, Swapnil
    Shukla, Rahul
    AAPS PHARMSCITECH, 2024, 25 (03)
  • [25] Filamentous nanostructures for drug delivery and regenerative therapies
    Stupp, Samuel I.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [26] Liposomal drug delivery: targeting therapies for neuroinflammation
    Roberts, N.
    Lovell, J.
    Price, J.
    Buckland, R.
    Xu, T.
    Atmosukarto, I.
    Bruestle, A.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 : 35 - 35
  • [27] Lysosomal therapies and drug delivery strategies: An overview
    Muro, Silvia
    ADVANCED DRUG DELIVERY REVIEWS, 2023, 202
  • [28] Liposomal drug delivery: targeting therapies for neuroinflammation
    Roberts, N.
    Lovell, J.
    Price, J.
    Buckland, R.
    Xu, T.
    Atmosukarto, I.
    Bruestle, A.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (4_SUPPL) : 35 - 35
  • [29] Drug Nanocrystals: A Delivery Channel for Antiviral Therapies
    Akanksha Chaturvedi
    Swapnil Sharma
    Rahul Shukla
    AAPS PharmSciTech, 25
  • [30] Therapies Based on Nanoparticles for Eye Drug Delivery
    Meza-Rios, Alejandra
    Navarro-Partida, Jose
    Armendariz-Borunda, Juan
    Santos, Arturo
    OPHTHALMOLOGY AND THERAPY, 2020, 9 (3) : 1 - 14